Phase I study of Treprostinil (LIQ-861) in healthy volunteers.

Trial Profile

Phase I study of Treprostinil (LIQ-861) in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jan 2018

At a glance

  • Drugs Treprostinil (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Adverse reactions
  • Sponsors Liquidia Technologies
  • Most Recent Events

    • 25 Jan 2018 According to the Liquidia Technologies media release, results from this trial were presented at the 12th Pulmonary Vascular Research Institute (PVRI) Annual World Congress on Pulmonary Vascular Disease.
    • 25 Jan 2018 Results presented in a Liquidia Technologies media release.
    • 10 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top